Fulgent Genetics to buy Bako Diagnostics assets and StrataDx
Fulgent Genetics has signed a definitive agreement to buy specific assets of Bako Diagnostics and to acquire StrataDx, two US-based laboratories,…
All articles by Gullapalli Prasanna
Gullapalli Prasanna
-
-
FDA approves Abbott’s Volt PFA system for atrial fibrillation
The US Food and Drug Administration (FDA) has granted approval for Abbott’s Volt PFA System, expanding treatment options for patients…
-
Neurable secures $35m to expedite BCI technology commercialisation
Neurable has completed a $35m Series A funding round to expedite the commercialisation of its patented compact brain-signal processing technology,…
-
ZOLL introduces next-gen wearable cardioverter defibrillator in US
Medical devices and related software solutions maker ZOLL has introduced its next-generation LifeVest wearable cardioverter defibrillator (WCD) in the US.…
-
Curasight doses first patient in Phase I brain cancer trial of uTREAT
Denmark-based Curasight has dosed the first patient in the Phase I clinical trial of its uTREAT diagnostic platform, targeting high-grade…
-
Abbott secures FDA and CE Mark approvals for Amplatzer delivery system
Abbott has secured the US Food and Drug Administration (FDA) and CE Mark approvals for its Amplatzer Piccolo delivery system,…
-
MARAbio introduces MAR-Autism Test to detect maternal autoantibodies
MARAbio Systems has commercially introduced a new blood test for identifying maternal autoantibody-related autism. The MAR-Autism Test is designed to…
-
FDA clears SleepRes’ Kricket PAP device for obstructive sleep apnoea
The US Food and Drug Administration (FDA) has granted 510(k) clearance to SleepRes’ Kairos positive airway pressure (KPAP)-powered Kricket PAP…
-
Zimmer Biomet and OneStep to deliver digital mobility analytics in orthopaedics
Zimmer Biomet has entered an exclusive partnership with OneStep, a digital fall prevention and mobility intelligence platform, to deliver a…
-
Thermedical treats first patient in trial of SERF ablation system for VT
Thermedical has treated the first patient in a pivotal clinical trial of its saline-enhanced radiofrequency (SERF) ablation system, used in…